Comparative Evaluation of Chlorhexidine Polymer Scaffold, 3Mixtatin, and Formocresol for Vital Primary Pulp Therapy: A Randomized 6-month Clinical Study
- PMID: 37496952
- PMCID: PMC10367291
- DOI: 10.5005/jp-journals-10005-2615
Comparative Evaluation of Chlorhexidine Polymer Scaffold, 3Mixtatin, and Formocresol for Vital Primary Pulp Therapy: A Randomized 6-month Clinical Study
Abstract
Introduction: The study was performed to evaluate and compare the clinical and radiographic efficacy of chlorhexidine (CHX) polymer scaffold, 3Mixtatin, and formocresol for vital primary pulp therapy-a randomized clinical study.
Materials and methods: A total of 120 primary molars were included from children aged between 6 and 8 years in this randomized clinical study based on inclusion and exclusion criteria and were randomly allocated into three groups (group I-CHX polymer scaffold, group II-3Mixtatin, and group III-formocresol. Pulpotomy was performed in a vital cariously exposed primary tooth with healthy periodontium where their retention is more beneficial than extraction. Subjects were followed up at 1, 3, and 6 months for clinical and radiographic evaluations.
Results: At 6 months of follow-up, the overall success rate of pulpotomy in groups I, II, and III was 56.41, 71.05, and 60.52% in each group, respectively. Nonsignificant difference (p > 0.05) was seen during intergroup comparison.
Conclusion: However, among the three materials used in this study, 3mixtatin comparatively had better results.
How to cite this article: Goel N. Comparative Evaluation of Chlorhexidine Polymer Scaffold, 3Mixtatin, and Formocresol for Vital Primary Pulp Therapy: A Randomized 6-month Clinical Study. Int J Clin Pediatr Dent 2023;16(3):478-482.
Keywords: Periodontal ligament widening; Root canal treatment; Stainless steel crown.
Copyright © 2023; The Author(s).
Conflict of interest statement
Source of support: Nil Conflict of interest: None
Similar articles
-
Comparative Evaluation of the Treatment Outcomes of Pulpotomy in Primary Molars Using Mineral Trioxide Aggregate and 3Mixtatin: A Randomized Clinical Trial.Int J Clin Pediatr Dent. 2023 Nov-Dec;16(6):810-815. doi: 10.5005/jp-journals-10005-2720. Int J Clin Pediatr Dent. 2023. PMID: 38344366 Free PMC article.
-
Clinical Radiographic Evaluation of 3Mixtatin and MTA in Primary Teeth Pulpotomies: A Randomized Controlled.Int J Clin Pediatr Dent. 2022;15(Suppl 1):S80-S86. doi: 10.5005/jp-journals-10005-2216. Int J Clin Pediatr Dent. 2022. PMID: 35645497 Free PMC article.
-
Randomized Controlled Trial of Pulpotomy in Primary Molars using MTA and Formocresol Compared to 3Mixtatin: A Novel Biomaterial.J Clin Pediatr Dent. 2018;42(5):361-366. doi: 10.17796/1053-4625-42.5.7. Epub 2018 May 15. J Clin Pediatr Dent. 2018. PMID: 29763354 Clinical Trial.
-
Success Rate of MTA Pulpotomy on Vital Pulp of Primary Molars: A 3-Year Observational Study.Int J Clin Pediatr Dent. 2016 Jul-Sep;9(3):222-227. doi: 10.5005/jp-journals-10005-1368. Epub 2016 Sep 27. Int J Clin Pediatr Dent. 2016. PMID: 27843254 Free PMC article. Review.
-
Comparison of 3Mixtatin and Mineral Trioxide Aggregate in Primary Teeth Pulpotomy: A Systematic Review.Cureus. 2025 Jan 11;17(1):e77284. doi: 10.7759/cureus.77284. eCollection 2025 Jan. Cureus. 2025. PMID: 39931597 Free PMC article. Review.
References
-
- Kratunova E, Silva D. Pulp therapy for primary and immature permanent teeth: an overview. Gen Dent. 2018;66(6):30–38. - PubMed
-
- Taha NA, Ahmad MB, Ghanim A. Assessment of mineral trioxide aggregrate pulpotomy in mature permanent teeth with carious exposures. Int Endod J. 2017;50(2):117–125. - PubMed
-
- Fuks AB. Current concepts in vital primary pulp therapy. Eur J paediatr Dent. 2002;3(3):115–20. - PubMed
LinkOut - more resources
Full Text Sources
Medical